Conjunctivitis screening: Difference between revisions

Jump to navigation Jump to search
Sara Mehrsefat (talk | contribs)
No edit summary
WikiBot (talk | contribs)
m Bot: Removing from Primary care
 
(6 intermediate revisions by 4 users not shown)
Line 2: Line 2:
{{Conjunctivitis}}
{{Conjunctivitis}}
{{CMG}} {{AE}} {{SaraM}}
{{CMG}} {{AE}} {{SaraM}}


==Overview==
==Overview==
[[Screening]] for conjunctivitis is not recommended. However, according to the Centers for Disease Control and Prevention (CDC), screening for [[sexually transmitted diseases|sexually transmitted diseases (STDs)]] is recommended among pregnant women to [[prevent]] conjunctivitis and other medical conditions in [[newborns]].<ref name= Conjunctivitis-screening > Centers for Disease Control and Prevention (2015) http://www.cdc.gov/std/tg2015/screening-recommendations.htm Accessed on June 29, 2016</ref>
General [[screening]] for conjunctivitis is not recommended. However, according to the Centers for Disease Control and Prevention (CDC), screening for [[sexually transmitted diseases|sexually transmitted diseases (STDs)]] is recommended among pregnant women to [[prevent]] conjunctivitis and other medical conditions in [[newborns]].<ref name= Conjunctivitis-screening> Centers for Disease Control and Prevention (2015) http://www.cdc.gov/std/tg2015/screening-recommendations.htm Accessed on June 29, 2016</ref>


==Screening==
==Screening==
[[Screening]] for conjunctivitis is not recommended. However, If a baby is born to a mother who has an [[sexually transmitted diseases|sexually transmitted diseases (STDs)]], during delivery the [[bacteria]] (''[[Chlamydia trachomatis]]'',  ''[[Neisseria gonorrhoeae]]'') or [[virus]] (''[[Herpes simplex virus]]'')  can pass from the [[birth canal]] into the baby's eyes, and cause septic conjunctivitis. Antibiotic ointment or eye drops is given to all babies immediately after birth to prevent conjunctivitis and other medical conditions in [[newborns]], . Occasionally, this treatment causes a mild chemical conjunctivitis, which usually clears up on its own. Screening has been recommended by CDC in pregnant women for sexually transmitted diseases (STDs) to prevent spreading the infection to the baby.<ref name= Conjunctivitis-screening > Centers for Disease Control and Prevention (2015) http://www.cdc.gov/std/tg2015/screening-recommendations.htm Accessed on June 29, 2016</ref><ref name=Screening-Chlamydia-Neisseria > Centers for Disease Control and Prevention (2002) http://www.cdc.gov/mmwr/PDF/rr/rr5115.pdf Accessed on June 29, 2016</ref>
General [[screening]] for conjunctivitis is not recommended. However, if a baby is born to a mother who has an [[sexually transmitted diseases|sexually transmitted disease (STD)]], during delivery the [[bacteria]] (''[[Chlamydia trachomatis]]'',  ''[[Neisseria gonorrhoeae]]'') or [[virus]] (''[[Herpes simplex virus]]'')  can pass from the [[birth canal]] into the baby's eyes, and cause septic conjunctivitis. Antibiotic ointment or eye drops is given to all babies immediately after birth to prevent conjunctivitis and other medical conditions in [[newborns]]. Occasionally, this treatment causes a mild chemical conjunctivitis, which is usually self-limiting. Screening has been recommended by CDC in pregnant women for sexually transmitted diseases (STDs) to prevent spreading the infection to the baby.<ref name= Conjunctivitis-screening > Centers for Disease Control and Prevention (2015) http://www.cdc.gov/std/tg2015/screening-recommendations.htm Accessed on June 29, 2016</ref><ref name=Screening-Chlamydia-Neisseria > Centers for Disease Control and Prevention (2002) http://www.cdc.gov/mmwr/PDF/rr/rr5115.pdf Accessed on June 29, 2016</ref>
 


{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
Line 32: Line 30:
*Evidence does not support routine HSV-2 serologic screening among asymptomatic pregnant women. However, type-specific serologic tests might be useful for identifying pregnant women at risk for HSV infection and guiding counseling regarding the risk for acquiring genital herpes during pregnancy
*Evidence does not support routine HSV-2 serologic screening among asymptomatic pregnant women. However, type-specific serologic tests might be useful for identifying pregnant women at risk for HSV infection and guiding counseling regarding the risk for acquiring genital herpes during pregnancy
|}
|}


==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WS}}
{{WH}}


[[Category:Ophthalmology]]
[[Category:Ophthalmology]]
[[Category:Primary care]]
[[Category:FinalQCRequired]]
[[Category:Emergency medicine]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
{{WS}}
{{WH}}

Latest revision as of 21:07, 29 July 2020

Conjunctivitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Conjunctivitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

Conjunctivitis screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Conjunctivitis screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Conjunctivitis screening

CDC on Conjunctivitis screening

Conjunctivitis screening in the news

Blogs on Conjunctivitis screening

Directions to Hospitals Treating Conjunctivitis

Risk calculators and risk factors for Conjunctivitis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

General screening for conjunctivitis is not recommended. However, according to the Centers for Disease Control and Prevention (CDC), screening for sexually transmitted diseases (STDs) is recommended among pregnant women to prevent conjunctivitis and other medical conditions in newborns.[1]

Screening

General screening for conjunctivitis is not recommended. However, if a baby is born to a mother who has an sexually transmitted disease (STD), during delivery the bacteria (Chlamydia trachomatis, Neisseria gonorrhoeae) or virus (Herpes simplex virus) can pass from the birth canal into the baby's eyes, and cause septic conjunctivitis. Antibiotic ointment or eye drops is given to all babies immediately after birth to prevent conjunctivitis and other medical conditions in newborns. Occasionally, this treatment causes a mild chemical conjunctivitis, which is usually self-limiting. Screening has been recommended by CDC in pregnant women for sexually transmitted diseases (STDs) to prevent spreading the infection to the baby.[1][2]

Organism Screening Recommendations in Pregnant Women
Chlamydia
  • All pregnant women under 25 years of age
  • Pregnant women, aged 25 and older if at increased risk
  • Retest during the 3rd trimester for women under 25 years of age or at risk
  • Pregnant women with chlamydial infection should have a test-of-cure 3-4 weeks after treatment and be retested within 3 months
Gonorrhea
  • All pregnant women under 25 years of age and older women if at increased risk
  • Retest 3 months after treatment
Herpes simplex virus
  • Evidence does not support routine HSV-2 serologic screening among asymptomatic pregnant women. However, type-specific serologic tests might be useful for identifying pregnant women at risk for HSV infection and guiding counseling regarding the risk for acquiring genital herpes during pregnancy

References

  1. 1.0 1.1 Centers for Disease Control and Prevention (2015) http://www.cdc.gov/std/tg2015/screening-recommendations.htm Accessed on June 29, 2016
  2. Centers for Disease Control and Prevention (2002) http://www.cdc.gov/mmwr/PDF/rr/rr5115.pdf Accessed on June 29, 2016

Template:WS Template:WH